Browse studies

Find your next paid study

7 recruiting studies matching your filters

A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years …

Renal Allograft Recipients

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Bristol-Myers SquibbNCT04877288

Observational

Clinical Evaluation of Freeze-Dried Bone Allograft Compared to Collagen-Enriched Bovine Xenograft for Alveolar Ridge Preservation of Anterior Extraction Sockets.

The purpose of this study is to compare two different bone graft materials (freeze-dried bone allograft, FDBA and collagen-enriched bovine xenograft, CEBX) tha…

Ridge PreservationAllograftsExtraction, Tooth+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT06722482

Phase 1

Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction

This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this …

Chronic Lung Allograft Dysfunction Lung MRI (CLAD)

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Sean FainNCT06406777

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Chronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month …

Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT01531257

Phase 3

a Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Biologic and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers.

BIOxHEAL is an investigational placental-derived biologic being evaluated for the treatment of nonhealing diabetic foot ulcers. Adults with type 1 or type 2 di…

Diabetic Foot UlcerAmniotic Membrane Placental AllograftBiologic

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Applied Biologics, LLCNCT07852338

Phase 3

Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET/CT Imaging)

Background: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those organs. Current imaging scans can see thi…

Allogeneic Stem Cell TransplantationLung Allograft TransplantationInterstitial Lung Disease+3 more

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT07613099

Phase 2

A Randomized, Placebo-controlled Phase 2 Study to Demonstrate the Safety and Efficacy of the Addition of LAM-001 to Standard Immunosuppression Therapy for Chronic Lung Allograft Dysfunction (BOS).

The goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS…

Bronchiolitis Obliterans SyndromeChronic Lung Allograft DysfunctionLung Transplantation

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Steven Hays, MDNCT06018766